This refers to the impairment or interference with the normal communication pathways mediated by adipokines, which are bioactive molecules secreted by adipose tissue. Adipokine signaling is central to metabolic regulation, inflammation, and insulin sensitivity throughout the body. Disruptions can lead to systemic metabolic dysfunction, a common factor in obesity and related hormonal imbalances. Clinically, this disruption is a major contributor to the pathology of insulin resistance.
Origin
The term combines Adipokine (hormones/cytokines secreted by fat tissue), Signaling (the process of communication between cells), and Disruption (a disturbance or interruption). Its foundation lies in endocrinology and immunometabolism, recognizing adipose tissue as a highly active endocrine organ. This recognition redefined fat tissue’s role from simple storage to complex hormonal regulation.
Mechanism
Disruption can occur at several points, including altered adipokine secretion rates, impaired receptor binding affinity on target cells, or post-receptor signaling pathway failure. For example, excess adipose tissue can lead to dysregulated leptin and adiponectin levels, which subsequently interferes with hypothalamic and peripheral tissue sensitivity. This malfunction perpetuates a cycle of chronic low-grade inflammation and metabolic resistance, further exacerbating hormonal imbalances.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.